IRIDEX Corp
NASDAQ:IRIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IRIDEX Corp
NASDAQ:IRIX
|
US |
|
C
|
Centrica PLC
DUS:CENB
|
UK |
|
Autobacs Seven Co Ltd
OTC:ATBSF
|
JP |
|
R
|
Rumble Resources Ltd
OTC:RTRFF
|
AU |
|
AMMB Holdings Bhd
OTC:AMMHF
|
MY |
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
IN |
|
D
|
Danske Bank A/S
XMUN:DSN
|
DK |
|
M
|
Microbot Medical Inc
F:CY9D
|
US |
|
P
|
PetroChina Co Ltd
DUS:PC6
|
CN |
|
Matador Resources Co
NYSE:MTDR
|
US |
Wall St Price Targets
IRIX Price Targets Summary
IRIDEX Corp
According to Wall Street analysts, the average 1-year price target for
IRIX is 2.805 USD with a low forecast of 2.7775 USD and a high forecast of 2.8875 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IRIX's stock price target?
Price Target
2.805
USD
According to Wall Street analysts, the average 1-year price target for
IRIX is 2.805 USD with a low forecast of 2.7775 USD and a high forecast of 2.8875 USD.
What is the Revenue forecast for IRIDEX Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for IRIDEX Corp?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 9%.